“My main motivation is to impact drug development using model-based approaches.”
Your role at Institut Roche and brief presentation of your professional background:
I joined Institut Roche in 2016 to support gRED (Genentech Research and Early Development) Clinical Pharmacology department. I am currently Group Director in the M&S group overseeing mainly projects in Oncology and Fibrotic disease.
I am Pharmacometrician and Clinical Pharmacologist with more than 20 years’ experience in M&S and drug development in hospitals (3 years), in the Pharma industry (11+ years, mainly in the Roche group) and consultancy (7+ years).
My Focus at Institut Roche:
I am providing M&S scientific oversight for half of the gRED Oncology portfolio and in fibrotic disease.
I am currently developing disease models for Multiple Myeloma and Geographic Atrophy and providing oversight in disease modeling in both oncology and non-oncology areas.
Cross-functional activities: I am also overseeing an initiative for the use of Real World Data (RWD) in Clinical Pharmacology. I am chairing the pediatric extrapolation cross-functional team.